Device Trial Radar · NCT07383688
Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Apr 1, 2026
Primary completion
Apr 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Neuspera Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 3, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Single-arm study where subjects' responses to a questionnaire for the traditional Sacral Neuromodulation (SNM) devices will be compared to the responses regarding the Neuspera SNM System.
Conditions
- Urinary Urge Incontinence
Interventions
Neuspera Implantable Sacral Neuromodulation SystemDevice
Stimulation of the Sacral Nerve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subject QuestionnaireTime frame: 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Specialty Clinical Research of St. Louis
St Louis, Missouri · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.